Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,058 | -62,425 | -49,132 | -28,980 | 17,378 |
| Depreciation Amortization | 30 | 117 | 87 | 58 | 29 |
| Accounts receivable | 1,376 | -1,491 | -1,751 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,874 | 1,666 | 1,636 | -406 | 4,224 |
| Other Working Capital | -2,366 | 4,859 | 3,152 | 967 | 6,889 |
| Other Operating Activity | 11,953 | 5,444 | 6,556 | 810 | -39,487 |
| Operating Cash Flow | $-14,939 | $-51,829 | $-39,452 | $-27,551 | $-10,967 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 33,100 | 33,100 | 33,100 | N/A |
| Debt Repayment | N/A | -36,143 | -33,817 | -32,910 | N/A |
| Common Stock Issued | 15,534 | 48,028 | 34,143 | 19,990 | 1,742 |
| Financing Cash Flow | $15,534 | $44,985 | $33,426 | $20,180 | $1,742 |
| Beginning Cash Position | 8,083 | 14,928 | 14,928 | 14,928 | 14,928 |
| End Cash Position | 8,677 | 8,083 | 8,901 | 7,556 | 5,703 |
| Net Cash Flow | $594 | $-6,845 | $-6,027 | $-7,371 | $-9,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,939 | -51,829 | -39,452 | -27,551 | -10,967 |
| Free Cash Flow | -14,939 | -51,829 | -39,452 | -27,551 | -10,967 |